<?xml version="1.0" encoding="UTF-8" ?><xml><records><record><database name="Full text missing 4.enl" path="/Users/s5068337/Downloads/Full text missing 4.enl">Full text missing 4.enl</database><source-app name="EndNote" version="20.2">EndNote</source-app><rec-number>11</rec-number><foreign-keys><key app="EN" db-id="fw59wwttoserv4ezxth5vtvjtzvvfezp2pxt">11</key></foreign-keys><ref-type name="Generic">13</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Zagaria, M. A. E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">M.A.E. Zagaria, MZ Associates, Inc, Hallowell, ME, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Addressing challenges of infection: Antibiotic adverse drug events in older adults</style></title></titles><pages><style face="normal" font="default" size="100%">6-12</style></pages><volume><style face="normal" font="default" size="100%">44</style></volume><number><style face="normal" font="default" size="100%">(Zagaria M.A.E.) MZ Associates, Inc, Hallowell, ME, United States</style></number><keywords><keyword><style face="normal" font="default" size="100%">antibiotic agent</style></keyword><keyword><style face="normal" font="default" size="100%">adverse drug reaction</style></keyword><keyword><style face="normal" font="default" size="100%">aging</style></keyword><keyword><style face="normal" font="default" size="100%">antibiotic therapy</style></keyword><keyword><style face="normal" font="default" size="100%">antimicrobial stewardship</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">comorbidity</style></keyword><keyword><style face="normal" font="default" size="100%">health education</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">infection</style></keyword><keyword><style face="normal" font="default" size="100%">medication compliance</style></keyword><keyword><style face="normal" font="default" size="100%">patient compliance</style></keyword><keyword><style face="normal" font="default" size="100%">practice guideline</style></keyword><keyword><style face="normal" font="default" size="100%">veterans health</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year></dates><isbn><style face="normal" font="default" size="100%">0148-4818</style></isbn><notes><style face="normal" font="default" size="100%">L2002299603&#xD;2019-08-14&#xD;2019-08-19</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L2002299603&amp;from=export</style></url></related-urls></urls></record><record><database name="Full text missing 4.enl" path="/Users/s5068337/Downloads/Full text missing 4.enl">Full text missing 4.enl</database><source-app name="EndNote" version="20.2">EndNote</source-app><rec-number>18</rec-number><foreign-keys><key app="EN" db-id="fw59wwttoserv4ezxth5vtvjtzvvfezp2pxt">18</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Takahashi, P.</style></author><author><style face="normal" font="default" size="100%">Trang, N.</style></author><author><style face="normal" font="default" size="100%">Chutka, D.</style></author><author><style face="normal" font="default" size="100%">Evans, J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Antibiotic prescribing and outcomes following treatment of symptomatic urinary tract infections in older women</style></title><secondary-title><style face="normal" font="default" size="100%">J Am Med Dir Assoc</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Am Med Dir Assoc</style></full-title></periodical><pages><style face="normal" font="default" size="100%">S11-5</style></pages><volume><style face="normal" font="default" size="100%">5</style></volume><number><style face="normal" font="default" size="100%">2 Suppl</style></number><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Bacterial Agents/adverse effects/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">*Drug Utilization</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Homes for the Aged/standards</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Long-Term Care/*standards</style></keyword><keyword><style face="normal" font="default" size="100%">Minnesota</style></keyword><keyword><style face="normal" font="default" size="100%">Nursing Homes/standards</style></keyword><keyword><style face="normal" font="default" size="100%">*Practice Patterns, Physicians&apos;</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Time Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Urinary Tract Infections/*drug therapy</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2004</style></year><pub-dates><date><style face="normal" font="default" size="100%">Mar-Apr</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1525-8610 (Print)&#xD;1525-8610</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVE: To describe antibiotic prescribing patterns for the treatment of urinary tract infections (UTI) among older women female long-term care facility residents and evaluate factors associated with adverse outcomes. STUDY DESIGN: Population-based retrospective cohort study. Population and sampling frame: All female residents of Olmsted County, Minnesota, aged 65 years and older, who were treated for urinary tract infections during calendar year 1996 were included in the study. DATA COLLECTION: Subjects&apos; complete medical records were reviewed and abstracted. Data collected included age, weight, serum creatinine, antibiotic treatment including dosage and duration, as well as retreatment and adverse drug events. RESULTS: A total of 196 subjects, ranging in age from 65 to 98 years, were diagnosed with UTI during calendar year 1996. Forty-four subjects were nursing home residents, and 152 resided in the community. The odds of prolonged antibiotic therapy (7 days or more) were 83 times higher among nursing home residents (Odds ratio = 82.7, 95% Confidence Interval, 11.1-617.7). The odds of receiving treatment for 10 days or longer were 5 times higher among nursing home residents compared to community subjects. The odds of underlying renal impairment necessitating dosage reduction were 3.6 times higher among nursing facility residents. Nursing facility residents were 7.3 times more likely to be treated with excessive dosages of antibiotics, 9.6 times more likely to experience adverse drug events, and 2.6 times more likely to receive retreatment for persistent or recurrent symptoms within one week of antibiotic discontinuation, compared to community subjects with UTI. CONCLUSIONS: Nursing home residents with UTI are treated for longer durations than community elderly. They experience a greater likelihood of receiving antibiotics in excessive dosage, a greater likelihood of adverse drug events, and a greater likelihood of retreatment compared with community subjects with UTI.</style></abstract><notes><style face="normal" font="default" size="100%">Takahashi, Paul&#xD;Trang, Nicholas&#xD;Chutka, Darryl&#xD;Evans, Jonathan&#xD;Journal Article&#xD;Multicenter Study&#xD;United States&#xD;J Am Med Dir Assoc. 2004 Mar-Apr;5(2 Suppl):S11-5. doi: 10.1097/00130535-200403001-00006.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1097/00130535-200403001-00006</style></electronic-resource-num></record><record><database name="Full text missing 4.enl" path="/Users/s5068337/Downloads/Full text missing 4.enl">Full text missing 4.enl</database><source-app name="EndNote" version="20.2">EndNote</source-app><rec-number>6</rec-number><foreign-keys><key app="EN" db-id="fw59wwttoserv4ezxth5vtvjtzvvfezp2pxt">6</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ray, W. A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Health Policy (WAR), Vanderbilt University School of Medicine, Nashville, Tennessee, USA.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Azithromycin associated with a reduction in 90-day mortality among older pneumonia patients, although a true clinical benefit is uncertain</style></title><secondary-title><style face="normal" font="default" size="100%">Evid Based Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Evid Based Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">226-7</style></pages><volume><style face="normal" font="default" size="100%">19</style></volume><number><style face="normal" font="default" size="100%">6</style></number><keywords><keyword><style face="normal" font="default" size="100%">Anti-Bacterial Agents/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Azithromycin/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Cardiovascular Diseases/*chemically induced</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Pneumonia/*drug therapy</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">Dec</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1356-5524 (Print)&#xD;1356-5524</style></isbn><notes><style face="normal" font="default" size="100%">1473-6810&#xD;Ray, Wayne A&#xD;R01 HL081707/HL/NHLBI NIH HHS/United States&#xD;HL081707/HL/NHLBI NIH HHS/United States&#xD;Comment&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Evid Based Med. 2014 Dec;19(6):226-7. doi: 10.1136/ebmed-2014-110061. Epub 2014 Aug 13.</style></notes><urls></urls><custom2><style face="normal" font="default" size="100%">PMC4435731</style></custom2><custom6><style face="normal" font="default" size="100%">NIHMS641062</style></custom6><electronic-resource-num><style face="normal" font="default" size="100%">10.1136/ebmed-2014-110061</style></electronic-resource-num></record><record><database name="Full text missing 4.enl" path="/Users/s5068337/Downloads/Full text missing 4.enl">Full text missing 4.enl</database><source-app name="EndNote" version="20.2">EndNote</source-app><rec-number>3</rec-number><foreign-keys><key app="EN" db-id="fw59wwttoserv4ezxth5vtvjtzvvfezp2pxt">3</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nicolle, L. E.</style></author><author><style face="normal" font="default" size="100%">Bjornson, J.</style></author><author><style face="normal" font="default" size="100%">Harding, G. K.</style></author><author><style face="normal" font="default" size="100%">MacDonell, J. A.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Bacteriuria in elderly institutionalized men</style></title><secondary-title><style face="normal" font="default" size="100%">N Engl J Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">N Engl J Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1420-5</style></pages><volume><style face="normal" font="default" size="100%">309</style></volume><number><style face="normal" font="default" size="100%">23</style></number><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Bacteria/isolation &amp; purification</style></keyword><keyword><style face="normal" font="default" size="100%">Bacteriuria/drug therapy/*epidemiology/mortality</style></keyword><keyword><style face="normal" font="default" size="100%">Drug Combinations</style></keyword><keyword><style face="normal" font="default" size="100%">Homes for the Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Random Allocation</style></keyword><keyword><style face="normal" font="default" size="100%">Sulfamethoxazole/administration &amp; dosage</style></keyword><keyword><style face="normal" font="default" size="100%">Tobramycin/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Trimethoprim/administration &amp; dosage</style></keyword><keyword><style face="normal" font="default" size="100%">Urine/microbiology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">1983</style></year><pub-dates><date><style face="normal" font="default" size="100%">Dec 8</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0028-4793 (Print)&#xD;0028-4793</style></isbn><abstract><style face="normal" font="default" size="100%">Over a two-year period we obtained monthly urine samples from all noncatheterized male residents on two geriatric wards to determine the occurrence and optimal management of bacteriuria in this population. Among 88 men the prevalence of bacteriuria was 33 per cent, and the incidence was 45 infections per 100 patients per year. Outcomes after single-dose therapy for asymptomatic bacteriuria with 43 courses of trimethoprim/sulfamethoxazole and 23 of tobramycin included 15 cures, 40 relapses, and 11 treatment failures. Thirty-six residents who had a relapse or in whom single-dose therapy failed were randomly assigned to receive therapy to eradicate bacteriuria or to receive no therapy. All 20 residents who received no therapy remained bacteriuric. The 16 residents who received therapy had fewer months of bacteriuria after randomization, but at the end of the study only one remained free of bacteriuria. Mortality and infectious morbidity after randomization were similar in the two groups. These data suggest that asymptomatic bacteriuria is common in elderly institutionalized men and that therapy is neither necessary nor effective.</style></abstract><notes><style face="normal" font="default" size="100%">Nicolle, L E&#xD;Bjornson, J&#xD;Harding, G K&#xD;MacDonell, J A&#xD;Clinical Trial&#xD;Journal Article&#xD;Randomized Controlled Trial&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;N Engl J Med. 1983 Dec 8;309(23):1420-5. doi: 10.1056/NEJM198312083092304.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.nejm.org/doi/pdf/10.1056/NEJM198312083092304?articleTools=true</style></url></related-urls><pdf-urls><url>internal-pdf://0266063985/Nicolle-1983-Bacteriuria in elderly institutio.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1056/nejm198312083092304</style></electronic-resource-num></record><record><database name="Full text missing 4.enl" path="/Users/s5068337/Downloads/Full text missing 4.enl">Full text missing 4.enl</database><source-app name="EndNote" version="20.2">EndNote</source-app><rec-number>15</rec-number><foreign-keys><key app="EN" db-id="fw59wwttoserv4ezxth5vtvjtzvvfezp2pxt">15</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Staszewska-Pistoni, M.</style></author><author><style face="normal" font="default" size="100%">Dontas, A. S.</style></author><author><style face="normal" font="default" size="100%">Giamarellou, H.</style></author><author><style face="normal" font="default" size="100%">Petrikkos, G.</style></author><author><style face="normal" font="default" size="100%">Zorbas, P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Athens University School of Medicine, Greece.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Effectiveness of ofloxacin therapy in preventing functional impairment and increased mortality in elderly patients with bacteriuria</style></title><secondary-title><style face="normal" font="default" size="100%">Drugs</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Drugs</style></full-title></periodical><pages><style face="normal" font="default" size="100%">374-5</style></pages><volume><style face="normal" font="default" size="100%">49 Suppl 2</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Infective Agents/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Bacteriuria/*drug therapy/*mortality</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Ofloxacin/*therapeutic use</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">1995</style></year></dates><isbn><style face="normal" font="default" size="100%">0012-6667 (Print)&#xD;0012-6667</style></isbn><notes><style face="normal" font="default" size="100%">Staszewska-Pistoni, M&#xD;Dontas, A S&#xD;Giamarellou, H&#xD;Petrikkos, G&#xD;Zorbas, P&#xD;Clinical Trial&#xD;Journal Article&#xD;Randomized Controlled Trial&#xD;New Zealand&#xD;Drugs. 1995;49 Suppl 2:374-5. doi: 10.2165/00003495-199500492-00102.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://link.springer.com/content/pdf/10.2165/00003495-199500492-00102.pdf</style></url></related-urls><pdf-urls><url>internal-pdf://1711960576/Staszewska-Pist-1995-Effectiveness of ofloxaci.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.2165/00003495-199500492-00102</style></electronic-resource-num></record><record><database name="Full text missing 4.enl" path="/Users/s5068337/Downloads/Full text missing 4.enl">Full text missing 4.enl</database><source-app name="EndNote" version="20.2">EndNote</source-app><rec-number>22</rec-number><foreign-keys><key app="EN" db-id="fw59wwttoserv4ezxth5vtvjtzvvfezp2pxt">22</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">van der Steen, J. T.</style></author><author><style face="normal" font="default" size="100%">van der Wal, G.</style></author><author><style face="normal" font="default" size="100%">Mehr, D. R.</style></author><author><style face="normal" font="default" size="100%">Ooms, M. E.</style></author><author><style face="normal" font="default" size="100%">Ribbe, M. W.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Institute for Research in Extramural Medicine (EMGO Institute) of the VU University Medical Center, Amsterdam, the Netherlands. j.vandersteen@vumc.nl</style></auth-address><titles><title><style face="normal" font="default" size="100%">End-of-life decision making in nursing home residents with dementia and pneumonia: Dutch physicians&apos; intentions regarding hastening death</style></title><secondary-title><style face="normal" font="default" size="100%">Alzheimer Dis Assoc Disord</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Alzheimer Dis Assoc Disord</style></full-title></periodical><pages><style face="normal" font="default" size="100%">148-55</style></pages><volume><style face="normal" font="default" size="100%">19</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Death</style></keyword><keyword><style face="normal" font="default" size="100%">*Decision Making</style></keyword><keyword><style face="normal" font="default" size="100%">Dementia/*complications/mortality</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">*Homes for the Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Nursing Homes</style></keyword><keyword><style face="normal" font="default" size="100%">Pneumonia/*etiology/mortality</style></keyword><keyword><style face="normal" font="default" size="100%">Surveys and Questionnaires</style></keyword><keyword><style face="normal" font="default" size="100%">*Withholding Treatment</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2005</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul-Sep</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0893-0341 (Print)&#xD;0893-0341</style></isbn><abstract><style face="normal" font="default" size="100%">When patients with severe dementia become acutely ill, little is known about the extent to which physicians take actions intended to hasten death. For 143 nursing home patients with dementia who died of pneumonia after a decision not to treat with antibiotics, we asked Dutch facility-employed physicians whether they intended to hasten death and any estimated life shortening. In 53% of cases, the physicians reported an explicit intention to hasten death; in another 41% of cases they reported taking into account a probability or certainty that the withholding of antibiotics or other palliative treatments would hasten death. Opiates were frequently used for symptom control (43%), but the administration of medications specifically intended to induce death was rare (2%). Considering all treatments, physicians estimated that life was shortened by 24 hours or less in 46% of patients and 1 month or longer in 24% of patients. The frequent withholding of antibiotics with an intention to hasten death may reflect a willingness to abandon a cure-oriented approach in dying patients for whom prolongation of life is not an aim. The results reflect the importance of explicit goals for medical interventions in patients with end-stage dementia where life-prolonging treatments may be seen as prolonging suffering.</style></abstract><notes><style face="normal" font="default" size="100%">van der Steen, Jenny T&#xD;van der Wal, Gerrit&#xD;Mehr, David R&#xD;Ooms, Marcel E&#xD;Ribbe, Miel W&#xD;AG18335/AG/NIA NIH HHS/United States&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, P.H.S.&#xD;United States&#xD;Alzheimer Dis Assoc Disord. 2005 Jul-Sep;19(3):148-55. doi: 10.1097/01.wad.0000175525.99104.b7.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1097/01.wad.0000175525.99104.b7</style></electronic-resource-num></record><record><database name="Full text missing 4.enl" path="/Users/s5068337/Downloads/Full text missing 4.enl">Full text missing 4.enl</database><source-app name="EndNote" version="20.2">EndNote</source-app><rec-number>5</rec-number><foreign-keys><key app="EN" db-id="fw59wwttoserv4ezxth5vtvjtzvvfezp2pxt">5</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">O&apos;Horo, J. C.</style></author><author><style face="normal" font="default" size="100%">Tande, A. J.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">In older patients with UTIs, deferring or not prescribing antibiotics was linked to adverse outcomes</style></title><secondary-title><style face="normal" font="default" size="100%">Ann Intern Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Ann Intern Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">Jc70</style></pages><volume><style face="normal" font="default" size="100%">170</style></volume><number><style face="normal" font="default" size="100%">12</style></number><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Bacterial Agents</style></keyword><keyword><style face="normal" font="default" size="100%">*Bacteremia</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Primary Health Care</style></keyword><keyword><style face="normal" font="default" size="100%">*Urinary Tract Infections</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jun 18</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0003-4819</style></isbn><notes><style face="normal" font="default" size="100%">1539-3704&#xD;O&apos;Horo, John C&#xD;Tande, Aaron J&#xD;Comment&#xD;Journal Article&#xD;United States&#xD;Ann Intern Med. 2019 Jun 18;170(12):JC70. doi: 10.7326/ACPJ201906180-070.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.7326/acpj201906180-070</style></electronic-resource-num></record><record><database name="Full text missing 4.enl" path="/Users/s5068337/Downloads/Full text missing 4.enl">Full text missing 4.enl</database><source-app name="EndNote" version="20.2">EndNote</source-app><rec-number>12</rec-number><foreign-keys><key app="EN" db-id="fw59wwttoserv4ezxth5vtvjtzvvfezp2pxt">12</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mody, L.</style></author><author><style face="normal" font="default" size="100%">Kauffman, C. A.</style></author><author><style face="normal" font="default" size="100%">McNeil, S. A.</style></author><author><style face="normal" font="default" size="100%">Galecki, A. T.</style></author><author><style face="normal" font="default" size="100%">Bradley, S. F.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">L. Mody, GRECC 11G, Veterans Affairs Medical Center, 2215 Fuller Rd., Ann Arbor, MI 48105, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Mupirocin-Based Decolonization of Staphylococcus aureus Carriers in Residents of 2 Long-Term Care Facilities: A Randomized, Double-Blind, Placebo-Controlled Trial</style></title><secondary-title><style face="normal" font="default" size="100%">Clinical Infectious Diseases</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Clinical Infectious Diseases</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1467-1474</style></pages><volume><style face="normal" font="default" size="100%">37</style></volume><number><style face="normal" font="default" size="100%">11</style></number><keywords><keyword><style face="normal" font="default" size="100%">placebo</style></keyword><keyword><style face="normal" font="default" size="100%">pseudomonic acid</style></keyword><keyword><style face="normal" font="default" size="100%">adult</style></keyword><keyword><style face="normal" font="default" size="100%">aged</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial strain</style></keyword><keyword><style face="normal" font="default" size="100%">bacterium carrier</style></keyword><keyword><style face="normal" font="default" size="100%">cellulitis</style></keyword><keyword><style face="normal" font="default" size="100%">clinical trial</style></keyword><keyword><style face="normal" font="default" size="100%">controlled clinical trial</style></keyword><keyword><style face="normal" font="default" size="100%">controlled study</style></keyword><keyword><style face="normal" font="default" size="100%">double blind procedure</style></keyword><keyword><style face="normal" font="default" size="100%">drug efficacy</style></keyword><keyword><style face="normal" font="default" size="100%">eradication therapy</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">infection prevention</style></keyword><keyword><style face="normal" font="default" size="100%">long term care</style></keyword><keyword><style face="normal" font="default" size="100%">major clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">male</style></keyword><keyword><style face="normal" font="default" size="100%">methicillin resistant Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">nursing home</style></keyword><keyword><style face="normal" font="default" size="100%">priority journal</style></keyword><keyword><style face="normal" font="default" size="100%">randomized controlled trial</style></keyword><keyword><style face="normal" font="default" size="100%">reinfection</style></keyword><keyword><style face="normal" font="default" size="100%">relapse</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus infection</style></keyword><keyword><style face="normal" font="default" size="100%">United States</style></keyword><keyword><style face="normal" font="default" size="100%">wound infection</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2003</style></year></dates><isbn><style face="normal" font="default" size="100%">1058-4838</style></isbn><abstract><style face="normal" font="default" size="100%">Mupirocin has been used in nursing homes to prevent the spread of methicillin-resistant Staphylococcus aureus (MRSA), despite the lack of controlled trials. In this double-blind, randomized study, the efficacy of intranasal mupirocin ointment versus that of placebo in reducing colonization and preventing infection was assessed among persistent carriers of S. aureus. Twice-daily treatment was given for 2 weeks, with a follow-up period of 6 months. Staphylococcal colonization rates were similar between residents at the Ann Arbor Veterans Affairs (VA) Extended Care Center, Michigan (33%), and residents at a community-based long-term care facility in Ann Arbor (36%), although those at the VA Center carried MRSA more often (58% vs. 35%; P = .017). After treatment, mupirocin had eradicated colonization in 93% of residents, whereas 85% of residents who received placebo remained colonized (P &lt; .001). At day 90 after study entry, 61% of the residents in the mupirocin group remained decolonized. Four patients did not respond to mupirocin therapy; 3 of the 4 had mupirocin-resistant S. aureus strains. Thirteen (86%) of 14 residents who became recolonized had the same pretherapy strain; no strain recovered during relapse was resistant to mupirocin. A trend toward reduction in infections was seen with mupirocin treatment.</style></abstract><notes><style face="normal" font="default" size="100%">L37494674&#xD;2003-12-22</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L37494674&amp;from=export</style></url><url><style face="normal" font="default" size="100%">http://dx.doi.org/10.1086/379325</style></url><url><style face="normal" font="default" size="100%">https://watermark.silverchair.com/37-11-1467.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAs8wggLLBgkqhkiG9w0BBwagggK8MIICuAIBADCCArEGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMu4mygH-Q_ncbpZg4AgEQgIICgpZyCjQ5yY9THfIyDSZdWqVTWR7LgROfWvMIwe3hoJ7W5cvRvZln1ah4MLHOQrppizFAkA1okM7Vv23h6vqcx1y9OW58dly0T3acxCfUCAg9oRQ8xM0R1ijh5yexpBCxj807in-LGlrxiNDA5s91qd7S65PAMhJPveSEAfdnhL1sKGxhuYFch_RozcmNwec2z5LeY-tGBnWJ2Z1stHExHDq6ziwN91vcpdN_FXGtQjuZf2MlxXVCp3DPGIsN2MI-uspy1N9AxTf01KwOyE_qLWPF9b7s_lDe7Zw4iRzL9S7vMOITlEghhWcmDAZIejLHE20JAspY52ztewFA4nocvLqwTZyyE05bgdUOo7Ty6cpfMXyqDWw_KiLhERqWVitGXjNqYmjYgdjY98LIjYw_fWR9l-Xp3vjp7S5mpgRu2DDstwk2JZ4_SGeCMAvm4AZzVIT7_YVBcQL-eK-lfGJ1I63MBYOd2juDzfB3_sPz-XStKd0QtPod58P0CTweIUt52ImYx2JyMAy5NsIyJgx-l3J4v5GOO4GyXmDH-ij5sB-X5y_qQsl8ai6rL-zQVwTpztbiM5RrwjKTF1dTISW8eCmbiwKYn2jY_VPoc9qs0GZLg6rA96CwyR3mScQUireXQaR21F8PrtsCcTA5Grz9dly3P5zI4kXpDhiFvRDFMVLUtlGrcdegnpL4LQcoZKg9MEw3KteGRm6GP6hjyz5i-O8a7DJs68IEYUGGi95jpum9_tFdC2Sl_0FiZlmwJxkrlzE5YCblPgAu6kgCLXtR4W-e0r-f0mUAqWQjGXyWq-f8ksr_wBUFhvOZsts2bdUD7eMWyaJb0NyzodSGuIxy80U7Cw</style></url></related-urls><pdf-urls><url>internal-pdf://2240338902/Mody-2003-Mupirocin-Based Decolonization of St.pdf</url></pdf-urls></urls><custom5><style face="normal" font="default" size="100%">14614669</style></custom5><electronic-resource-num><style face="normal" font="default" size="100%">10.1086/379325</style></electronic-resource-num></record><record><database name="Full text missing 4.enl" path="/Users/s5068337/Downloads/Full text missing 4.enl">Full text missing 4.enl</database><source-app name="EndNote" version="20.2">EndNote</source-app><rec-number>20</rec-number><foreign-keys><key app="EN" db-id="fw59wwttoserv4ezxth5vtvjtzvvfezp2pxt">20</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">van der Steen, J. T.</style></author><author><style face="normal" font="default" size="100%">Ooms, M. E.</style></author><author><style face="normal" font="default" size="100%">van der Wal, G.</style></author><author><style face="normal" font="default" size="100%">Ribbe, M. W.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Institute for Research in Extramural Medicine, Department of Nursing Home Medicine, VU University Medical Center, Amsterdam, The Netherlands. jt.van_der_steen.emgo@med.vu.nl.or</style></auth-address><titles><title><style face="normal" font="default" size="100%">Pneumonia: the demented patient&apos;s best friend? Discomfort after starting or withholding antibiotic treatment</style></title><secondary-title><style face="normal" font="default" size="100%">J Am Geriatr Soc</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Am Geriatr Soc</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1681-8</style></pages><volume><style face="normal" font="default" size="100%">50</style></volume><number><style face="normal" font="default" size="100%">10</style></number><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Bacterial Agents/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Decision Making</style></keyword><keyword><style face="normal" font="default" size="100%">Dementia/*complications/drug therapy/mortality</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Linear Models</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Nursing Homes</style></keyword><keyword><style face="normal" font="default" size="100%">Pain/etiology</style></keyword><keyword><style face="normal" font="default" size="100%">Pain Measurement</style></keyword><keyword><style face="normal" font="default" size="100%">*Palliative Care</style></keyword><keyword><style face="normal" font="default" size="100%">Pneumonia/*complications/*drug therapy/mortality</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Severity of Illness Index</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2002</style></year><pub-dates><date><style face="normal" font="default" size="100%">Oct</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0002-8614 (Print)&#xD;0002-8614</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVES: To assess suffering in demented nursing home patients with pneumonia treated with antibiotics or without antibiotics. This study should provide the first empirical data on whether pneumonia is a &quot;friend&quot; or an &quot;enemy&quot; of demented patients and promote a debate on appropriate palliative care. DESIGN: Prospective cohort study. SETTING: Psychogeriatric wards of 61 nursing homes in the Netherlands. PARTICIPANTS: Six hundred sixty-two demented patients with pneumonia treated with (77%) or without (23%) antibiotics. MEASUREMENTS: Using an observational scale (Discomfort Scale-Dementia of Alzheimer Type), discomfort was assessed at the time of the pneumonia treatment decision and periodically thereafter for 3 months or until death. (Thirty-nine percent of patients treated with antibiotics and 93% of patients treated without antibiotics died within 3 months.) Physicians also offered a retrospective judgment of discomfort 2 weeks before the treatment decision. In addition, pneumonia symptoms were assessed at baseline and on follow-up. Linear regression was performed with discomfort shortly before death as an outcome. RESULTS: A peak in discomfort was observed at baseline. Compared with surviving patients treated with antibiotics, the level of discomfort was generally higher in patients in whom antibiotic treatment was withheld and in nonsurvivors. However, these same patients had more discomfort before the pneumonia. Breathing problems were most prominent. Shortly before death from pneumonia, discomfort increased. Discomfort was higher shortly before death when pneumonia was the final cause of death than with death from other causes. CONCLUSION: Irrespective of antibiotic treatment, pneumonia causes substantial suffering in demented patients. Adequate symptomatic treatment deserves priority attention.</style></abstract><notes><style face="normal" font="default" size="100%">van der Steen, Jenny T&#xD;Ooms, Marcel E&#xD;van der Wal, Gerrit&#xD;Ribbe, Miel W&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;J Am Geriatr Soc. 2002 Oct;50(10):1681-8. doi: 10.1046/j.1532-5415.2002.50460.x.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://agsjournals.onlinelibrary.wiley.com/doi/full/10.1046/j.1532-5415.2002.50460.x?sid=nlm%3Apubmed</style></url></related-urls><pdf-urls><url>internal-pdf://2331367260/Pneumonia_ The Demented Patient&apos;s Best Friend_.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1046/j.1532-5415.2002.50460.x</style></electronic-resource-num></record><record><database name="Full text missing 4.enl" path="/Users/s5068337/Downloads/Full text missing 4.enl">Full text missing 4.enl</database><source-app name="EndNote" version="20.2">EndNote</source-app><rec-number>14</rec-number><foreign-keys><key app="EN" db-id="fw59wwttoserv4ezxth5vtvjtzvvfezp2pxt">14</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nicolle, L. E.</style></author><author><style face="normal" font="default" size="100%">Mayhew, W. J.</style></author><author><style face="normal" font="default" size="100%">Bryan, L.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Prospective randomized comparison of therapy and no therapy for asymptomatic bacteriuria in institutionalized elderly women</style></title><secondary-title><style face="normal" font="default" size="100%">Am J Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Am J Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">27-33</style></pages><volume><style face="normal" font="default" size="100%">83</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Bacterial Agents/adverse effects/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Bacteria/isolation &amp; purification</style></keyword><keyword><style face="normal" font="default" size="100%">Bacteriuria/*drug therapy/epidemiology/microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">Clinical Trials as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Homes for the Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">*Institutionalization</style></keyword><keyword><style face="normal" font="default" size="100%">Nursing Homes</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Random Allocation</style></keyword><keyword><style face="normal" font="default" size="100%">Recurrence</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">1987</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0002-9343 (Print)&#xD;0002-9343</style></isbn><abstract><style face="normal" font="default" size="100%">Fifty elderly (mean age, 83.4 +/- 8.8 years) institutionalized women with asymptomatic bacteriuria were randomly assigned either to receive therapy for treatment of all episodes of bacteriuria identified on monthly culture or to receive no therapy unless symptoms developed. Subjects were followed for one year. The therapy group had a mean monthly prevalence of bacteriuria 31 +/- 15 percent lower than those in the no-therapy group, but periods free of bacteriuria lasting six months or longer were documented for only five (24 percent) subjects. For residents receiving no therapy, 71 percent showed persistent infection with the same organism(s). Antimicrobial therapy was associated with an increased incidence of reinfection (1.67 versus 0.87 per patient-year) and adverse antimicrobial drug effects (0.51 versus 0.046 per patient-year) as well as isolation of increasingly resistant organisms in recurrent infection when compared with no therapy. No differences in genitourinary morbidity or mortality were observed between the groups. Thus, despite a lowered prevalence of bacteriuria, no short-term benefits were identified and some harmful effects were observed with treatment of asymptomatic bacteriuria. These data support current recommendations of no therapy for asymptomatic bacteriuria in this population.</style></abstract><notes><style face="normal" font="default" size="100%">Nicolle, L E&#xD;Mayhew, W J&#xD;Bryan, L&#xD;Clinical Trial&#xD;Comparative Study&#xD;Journal Article&#xD;Randomized Controlled Trial&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Am J Med. 1987 Jul;83(1):27-33. doi: 10.1016/0002-9343(87)90493-1.</style></notes><urls><pdf-urls><url>internal-pdf://3998466364/Nicolle 1987.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/0002-9343(87)90493-1</style></electronic-resource-num></record><record><database name="Full text missing 4.enl" path="/Users/s5068337/Downloads/Full text missing 4.enl">Full text missing 4.enl</database><source-app name="EndNote" version="20.2">EndNote</source-app><rec-number>13</rec-number><foreign-keys><key app="EN" db-id="fw59wwttoserv4ezxth5vtvjtzvvfezp2pxt">13</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mott, P. D.</style></author><author><style face="normal" font="default" size="100%">Barker, W. H.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Preventive Medicine, University of Rochester School of Medicine and Dentistry, New York.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Treatment decisions for infections occurring in nursing home residents</style></title><secondary-title><style face="normal" font="default" size="100%">J Am Geriatr Soc</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Am Geriatr Soc</style></full-title></periodical><pages><style face="normal" font="default" size="100%">820-4</style></pages><volume><style face="normal" font="default" size="100%">36</style></volume><number><style face="normal" font="default" size="100%">9</style></number><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Bacterial Infections/mortality/*therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Decision Making</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitalization</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">*Nursing Homes</style></keyword><keyword><style face="normal" font="default" size="100%">Patient Care Planning</style></keyword><keyword><style face="normal" font="default" size="100%">*Patient Selection</style></keyword><keyword><style face="normal" font="default" size="100%">Pneumonia/therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Respiratory Tract Infections/therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Retrospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Urinary Tract Infections/therapy</style></keyword><keyword><style face="normal" font="default" size="100%">*Withholding Treatment</style></keyword><keyword><style face="normal" font="default" size="100%">Empirical Approach</style></keyword><keyword><style face="normal" font="default" size="100%">Professional Patient Relationship</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">1988</style></year><pub-dates><date><style face="normal" font="default" size="100%">Sep</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0002-8614 (Print)&#xD;0002-8614</style></isbn><abstract><style face="normal" font="default" size="100%">This retrospective study examines the effect of guidelines on clinical decision-making in the treatment of acute infections in nursing home residents. Among 110 patients followed over 7 years, infections caused 54% of acute medically attended problems, 48% of hospitalizations, and 63% of deaths. Patients designated to receive comfort care, when compared with maximum care patients, had a higher percentage of acute problems, hospitalizations, and deaths caused by infections. Antibiotic treatment was given far less often to comfort care patients with respiratory, urinary tract, and skin infections. Implications of such an intervention in nursing home care are discussed.</style></abstract><notes><style face="normal" font="default" size="100%">Mott, P D&#xD;Barker, W H&#xD;Journal Article&#xD;United States&#xD;J Am Geriatr Soc. 1988 Sep;36(9):820-4. doi: 10.1111/j.1532-5415.1988.tb04266.x.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://agsjournals.onlinelibrary.wiley.com/doi/abs/10.1111/j.1532-5415.1988.tb04266.x?sid=nlm%3Apubmed</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1111/j.1532-5415.1988.tb04266.x</style></electronic-resource-num></record><record><database name="Full text missing 4.enl" path="/Users/s5068337/Downloads/Full text missing 4.enl">Full text missing 4.enl</database><source-app name="EndNote" version="20.2">EndNote</source-app><rec-number>19</rec-number><foreign-keys><key app="EN" db-id="fw59wwttoserv4ezxth5vtvjtzvvfezp2pxt">19</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">van der Steen, J. T.</style></author><author><style face="normal" font="default" size="100%">Ooms, M. E.</style></author><author><style face="normal" font="default" size="100%">Adèr, H. J.</style></author><author><style face="normal" font="default" size="100%">Ribbe, M. W.</style></author><author><style face="normal" font="default" size="100%">van der Wal, G.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Institute for Research in Extramural Medicine, Amsterdam, the Netherlands. jt.van_der_steen.emgo@med.vu.nl</style></auth-address><titles><title><style face="normal" font="default" size="100%">Withholding antibiotic treatment in pneumonia patients with dementia: a quantitative observational study</style></title><secondary-title><style face="normal" font="default" size="100%">Arch Intern Med</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Arch Intern Med</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1753-60</style></pages><volume><style face="normal" font="default" size="100%">162</style></volume><number><style face="normal" font="default" size="100%">15</style></number><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Bacterial Agents/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Cohort Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Decision Making</style></keyword><keyword><style face="normal" font="default" size="100%">Dementia/*complications/*drug therapy/mortality</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Netherlands</style></keyword><keyword><style face="normal" font="default" size="100%">Physicians/psychology</style></keyword><keyword><style face="normal" font="default" size="100%">Pneumonia/*complications/*drug therapy/mortality</style></keyword><keyword><style face="normal" font="default" size="100%">Severity of Illness Index</style></keyword><keyword><style face="normal" font="default" size="100%">Survival Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Treatment Outcome</style></keyword><keyword><style face="normal" font="default" size="100%">*Withholding Treatment</style></keyword><keyword><style face="normal" font="default" size="100%">Death and Euthanasia</style></keyword><keyword><style face="normal" font="default" size="100%">Empirical Approach</style></keyword><keyword><style face="normal" font="default" size="100%">Mental Health Therapies</style></keyword><keyword><style face="normal" font="default" size="100%">Professional Patient Relationship</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2002</style></year><pub-dates><date><style face="normal" font="default" size="100%">Aug 12-26</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0003-9926 (Print)&#xD;0003-9926</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: Pneumonia is a life-threatening disease in nursing home patients with dementia. Physicians and families face choices about whether to withhold antibiotics when patients are expected to die soon or when treatment may be burdensome. However, little information exists on what factors influence this complex decision-making process. OBJECTIVE: To identify factors associated with decisions on whether to withhold curative antibiotic treatment in patients with dementia who have pneumonia. METHODS: We performed an observational cohort study with 3-month monitoring for cure and death. Patients with pneumonia (N = 706) were enrolled in nursing home units for patients with dementia from all over the Netherlands (61 nursing homes). Characteristics of patients, physicians, and facilities were related to the outcome of withholding antibiotic treatment. RESULTS: In 23% of the patients, antibiotic treatment was withheld. The other patients received antibiotics with palliative (8%) or curative (69%) intent. Compared with the patients who received antibiotics with curative intent, patients in whom antibiotic treatment was withheld had more severe dementia, had more severe pneumonia, had lower food and fluid intake, and were more often dehydrated. In addition, withholding antibiotics occurred more often in the summer and in patients with an initial episode of pneumonia. Characteristics of facilities and physicians were unrelated to the decision. However, considerable variation occurred in how patient age, aspiration, and history of pneumonia were related to decision making by individual physicians. CONCLUSIONS: In the Netherlands, antibiotic treatment is commonly withheld in pneumonia patients with severe dementia who are especially frail. Understanding the circumstances in which this occurs can illuminate the international discussion of appropriate dementia care.</style></abstract><notes><style face="normal" font="default" size="100%">van der Steen, Jenny T&#xD;Ooms, Marcel E&#xD;Adèr, Herman J&#xD;Ribbe, Miel W&#xD;van der Wal, Gerrit&#xD;Comparative Study&#xD;Evaluation Study&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Arch Intern Med. 2002 Aug 12-26;162(15):1753-60. doi: 10.1001/archinte.162.15.1753.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/754092/ioi10658.pdf</style></url></related-urls><pdf-urls><url>internal-pdf://3237720427/van der Steen-2002-Withholding antibiotic trea.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1001/archinte.162.15.1753</style></electronic-resource-num></record><record><database name="Full text missing 4.enl" path="/Users/s5068337/Downloads/Full text missing 4.enl">Full text missing 4.enl</database><source-app name="EndNote" version="20.2">EndNote</source-app><rec-number>21</rec-number><foreign-keys><key app="EN" db-id="fw59wwttoserv4ezxth5vtvjtzvvfezp2pxt">21</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">van der Steen, J. T.</style></author><author><style face="normal" font="default" size="100%">Ooms, M. E.</style></author><author><style face="normal" font="default" size="100%">van der Wal, G.</style></author><author><style face="normal" font="default" size="100%">Ribbe, M. W.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Institute for Research in Extramural Medicine (EMGO Institute), VU University Medical Center, Amsterdam, Netherlands. j.vandersteen@vumc.nl</style></auth-address><titles><title><style face="normal" font="default" size="100%">Withholding or starting antibiotic treatment in patients with dementia and pneumonia: prediction of mortality with physicians&apos; judgment of illness severity and with specific prognostic models</style></title><secondary-title><style face="normal" font="default" size="100%">Med Decis Making</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Med Decis Making</style></full-title></periodical><pages><style face="normal" font="default" size="100%">210-21</style></pages><volume><style face="normal" font="default" size="100%">25</style></volume><number><style face="normal" font="default" size="100%">2</style></number><keywords><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Bacterial Agents/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Cross Infection/*drug therapy/microbiology/mortality</style></keyword><keyword><style face="normal" font="default" size="100%">*Decision Support Systems, Clinical</style></keyword><keyword><style face="normal" font="default" size="100%">*Decision Support Techniques</style></keyword><keyword><style face="normal" font="default" size="100%">Dementia/*physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Judgment</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Netherlands/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">Nursing Homes</style></keyword><keyword><style face="normal" font="default" size="100%">Pneumonia/*drug therapy/mortality/physiopathology</style></keyword><keyword><style face="normal" font="default" size="100%">Practice Patterns, Physicians&apos;/*statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Prognosis</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">*Severity of Illness Index</style></keyword><keyword><style face="normal" font="default" size="100%">Withholding Treatment/*statistics &amp; numerical data</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2005</style></year><pub-dates><date><style face="normal" font="default" size="100%">Mar-Apr</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0272-989X (Print)&#xD;0272-989x</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND: To help decision makers plan treatment, the authors assessed clinical predictors of mortality from nursing home-acquired pneumonia in patients with dementia. METHODS: Pneumonia patients treated without (n = 165) or with antibiotics (n = 541) were enrolled in a prospective cohort study in 61 nursing homes. RESULTS: In both groups, clinical judgment of illness severity was a strong predictor for 1-week mortality. Despite large differences in frailty and mortality (83% in untreated patients and 15% in treated patients), separate multivariable logistic models included similar specific predictors. DISCUSSION: Despite profound differences between the 2 independent groups, predictors for short-term mortality were largely similar. We found that, when combined with physicians&apos; clinical judgment, 3 readily assessed predictors (respiratory rate, fluid intake, and eating dependency) helped predict mortality. Our results, if confirmed in an independent population, can help make decision making about antibiotic treatment of pneumonia in patients with dementia more evidence-based.</style></abstract><notes><style face="normal" font="default" size="100%">van der Steen, Jenny T&#xD;Ooms, Marcel E&#xD;van der Wal, Gerrit&#xD;Ribbe, Miel W&#xD;Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Med Decis Making. 2005 Mar-Apr;25(2):210-21. doi: 10.1177/0272989X05275400.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://journals.sagepub.com/doi/pdf/10.1177/0272989X05275400</style></url></related-urls><pdf-urls><url>internal-pdf://0127597694/van der Steen-2005-Withholding or starting ant.pdf</url></pdf-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1177/0272989x05275400</style></electronic-resource-num></record></records></xml>